• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Addus HomeCare Corporation (Amendment)

    1/22/24 2:03:09 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care
    Get the next $ADUS alert in real time by email
    SC 13G/A 1 us0067391062_012224.txt us0067391062_012224.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 2) Addus HomeCare Corp -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 006739106 -------------------------------------------------------- (CUSIP Number) December 31, 2023 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 006739106 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 2575212 (6) Shared voting power 0 (7) Sole dispositive power 2613406 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 2613406 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 16.1% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- Addus HomeCare Corp Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- 6303 COWBOYS WAY, SUITE 600 FRISCO TX 75034 Item 2. 2(a) Name of person filing: ---------------------------------------------------------------------- BlackRock, Inc. 2(b) Address or principal business office or, if none, residence: ----------------------------------------------------------------------- BlackRock, Inc. 50 Hudson Yards New York, NY 10001 2(c) Citizenship: -------------------------------------------------------------------- See Item 4 of Cover Page 2(d) Title of class of securities: ------------------------------------------------------------------- Common Stock 2(e) CUSIP No.: See Cover Page Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: [ ] Broker or dealer registered under Section 15 of the Act; [ ] Bank as defined in Section 3(a)(6) of the Act; [ ] Insurance company as defined in Section 3(a)(19) of the Act; [ ] Investment company registered under Section 8 of the Investment Company Act of 1940; [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); [ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); [X] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940; [ ] A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J); [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. Amount beneficially owned: 2613406 Percent of class 16.1% Number of shares as to which such person has: Sole power to vote or to direct the vote 2575212 Shared power to vote or to direct the vote 0 Sole power to dispose or to direct the disposition of 2613406 Shared power to dispose or to direct the disposition of 0 Item 5. Ownership of 5 Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ ]. Item 6. Ownership of More than 5 Percent on Behalf of Another Person If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The interest of 1 such person, iShares Core S&P Small-Cap ETF, in the common stock of Addus HomeCare Corp is more than five percent of the total outstanding common stock. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. See Exhibit A Item 8. Identification and Classification of Members of the Group If a group has filed this schedule pursuant to Rule 13d-1(b)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identity of each member of the group. Item 9. Notice of Dissolution of Group Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5. Item 10. Certifications By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: January 22, 2024 BlackRock, Inc. Signature: Spencer Fleming ------------------------------------------- Name/Title Attorney-In-Fact The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001). Exhibit A Subsidiary Aperio Group, LLC BlackRock Advisors, LLC BlackRock (Netherlands) B.V. BlackRock Fund Advisors* BlackRock Institutional Trust Company, National Association BlackRock Asset Management Ireland Limited BlackRock Financial Management, Inc. BlackRock Asset Management Schweiz AG BlackRock Investment Management, LLC BlackRock Investment Management (UK) Limited BlackRock Asset Management Canada Limited BlackRock (Luxembourg) S.A. BlackRock Investment Management (Australia) Limited BlackRock Fund Managers Ltd *Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Exhibit B POWER OF ATTORNEY The undersigned, BlackRock, Inc., a corporation duly organized under the laws of the State of Delaware, United States (the "Company"), does hereby make, constitute and appoint each of Eric Andruczyk, Richard Cundiff, R. Andrew Dickson, III, Spencer Fleming, Daniel Goldmintz, Laura Hildner, Elizabeth Kogut, David Maryles, Christopher Meade, Una Neary, Charles Park, Daniel Riemer, David Rothenberg and Brenda Schulz, acting severally, as its true and lawful attorneys-in-fact, for the purpose of, from time to time, executing, in its name and on its behalf and on behalf of its direct and indirect subsidiaries, any and all documents, certificates, instruments, statements, filings, agreements and amendments (collectively, "documents") determined by such person to be necessary or appropriate to comply with ownership or control-person reporting requirements imposed by any United States or non-United States governmental or regulatory authority, including, without limitation, Schedules 13D and 13G and Forms 3, 4, 5, 13F and 13H and any amendments to any of the foregoing as may be required to be filed with the Securities and Exchange Commission, and delivering, furnishing or filing any such documents with the appropriate governmental or regulatory authority or other person, and giving and granting to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully and to all intents and purposes as the Company and/or its direct and indirect subsidiaries, as applicable, might or could do if personally present by one of its authorized signatories, hereby ratifying and confirming all that said attorney-in-fact shall lawfully do or cause to be done by virtue hereof. Any such determination by an attorney-in-fact named herein shall be conclusively evidenced by such person's execution, delivery, furnishing or filing of the applicable document. This power of attorney shall expressly revoke the power of attorney dated 2nd day of January, 2019 in respect of the subject matter hereof, shall be valid from the date hereof and shall remain in full force and effect until either revoked in writing by the Company, or, in respect of any attorney-in-fact named herein, until such person ceases to be an employee of the Company or one of its affiliates. IN WITNESS WHEREOF, the undersigned has caused this power of attorney to be executed as of this 30th day of April, 2023. BlackRock, Inc. By: /s/ R. Andrew Dickson, III Name: R. Andrew Dickson, III Title: Corporate Secretary
    Get the next $ADUS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ADUS

    DatePrice TargetRatingAnalyst
    12/16/2024$150.00Mkt Outperform
    JMP Securities
    10/11/2024$150.00Overweight
    KeyBanc Capital Markets
    6/28/2024$136.00Outperform
    Macquarie
    4/23/2024$83.00Equal Weight → Underweight
    Barclays
    3/6/2024$88.00Equal Weight
    Barclays
    2/5/2024Outperform
    William Blair
    12/12/2023$105.00Outperform
    TD Cowen
    6/29/2022$101.00Buy
    Stifel
    More analyst ratings

    $ADUS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP/Chief Information Officer Wattenbarger Michael D. sold $235,175 worth of shares (2,045 units at $115.00), decreasing direct ownership by 21% to 7,796 units (SEC Form 4)

      4 - Addus HomeCare Corp (0001468328) (Issuer)

      5/29/25 4:30:07 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • EVP/Chief Development Officer Blessing Cliff Donald sold $18,008 worth of shares (178 units at $101.17), decreasing direct ownership by 2% to 10,401 units (SEC Form 4)

      4 - Addus HomeCare Corp (0001468328) (Issuer)

      4/22/25 4:30:22 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • EVP/Chief Financial Officer Poff Brian was granted 31,750 shares, increasing direct ownership by 96% to 64,719 units (SEC Form 4)

      4 - Addus HomeCare Corp (0001468328) (Issuer)

      3/12/25 4:00:12 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • JMP Securities initiated coverage on Addus HomeCare with a new price target

      JMP Securities initiated coverage of Addus HomeCare with a rating of Mkt Outperform and set a new price target of $150.00

      12/16/24 6:21:27 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • KeyBanc Capital Markets initiated coverage on Addus HomeCare with a new price target

      KeyBanc Capital Markets initiated coverage of Addus HomeCare with a rating of Overweight and set a new price target of $150.00

      10/11/24 7:29:16 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Macquarie initiated coverage on Addus HomeCare with a new price target

      Macquarie initiated coverage of Addus HomeCare with a rating of Outperform and set a new price target of $136.00

      6/28/24 7:30:03 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $ADUS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Addus HomeCare to Participate in Upcoming Investor Conferences in May

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its participation at the following investor conferences in May: BofA Securities 2025 Health Care Conference in Las Vegas, Nevada, on Wednesday, May 14, 2025. Dirk Allison, Chairman and Chief Executive Officer, Brad Bickham, President and Chief Operating Officer, and Brian Poff, Executive Vice President and Chief Financial Officer, will present at 9:20 a.m. Pacific Time / 11:20 a.m. Central Time on Wednesday, May 14, 2025. 2025 RBC Capital Markets Global Healthcare Conference in New York on Tuesday, May 20, 2025. Dirk Allison, Chairman and Chief Executive Officer and Brian Poff, Executive Vice Pr

      5/6/25 11:00:00 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Announces First Quarter 2025 Financial Results

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights: Net Service Revenues Grow 20.3% to $337.7 Million Net Income of $21.2 Million, or $1.16 per Diluted Share Adjusted Net Income per Diluted Share Increases 17.4% year-over-year to $1.42 Adjusted EBITDA Increases 25.1% year-over-year to $40.6 Million Cash Flow from Operations of $18.9 Million Overview Net service revenues were $337.7 million for the first quarter of 2025, a 20.3% increase compared with $280.7 million for the first quarter of 2024. Net income was $21.2 million for the first quar

      5/5/25 4:05:00 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Announces First Quarter 2025 Earnings Release and Conference Call

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that it will release earnings for the first quarter ended March 31, 2025, on Monday, May 5, 2025, after the market close. Addus HomeCare will host a conference call on Tuesday, May 6, 2025, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Brad Bickham, President and COO. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available through midnight on May 13,

      4/21/25 11:00:00 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G filed by Addus HomeCare Corporation

      SC 13G - Addus HomeCare Corp (0001468328) (Subject)

      11/13/24 9:44:25 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Addus HomeCare Corporation (Amendment)

      SC 13G/A - Addus HomeCare Corp (0001468328) (Subject)

      2/13/24 4:55:59 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Addus HomeCare Corporation (Amendment)

      SC 13G/A - Addus HomeCare Corp (0001468328) (Subject)

      1/22/24 2:03:09 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    Leadership Updates

    Live Leadership Updates

    See more
    • Axonics® Announces Appointment of Dr. Esteban López to its Board of Directors

      Axonics, Inc. (NASDAQ:AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced the appointment of Esteban López, M.D., MBA, to its board of directors, effective immediately. "Axonics is fortunate to have someone of Dr. López's character and extensive experience join our board of directors," said Raymond W. Cohen, CEO of Axonics. "Given his thought leadership in healthcare, Dr. López will be a valuable adviser to Axonics as we continue to execute on our ambitious growth objectives." Dr. López is the Americas healthcare and life sciences Market Lead at Google Cloud with multinational

      7/15/21 6:00:00 AM ET
      $AXNX
      $ADUS
      Medical/Dental Instruments
      Health Care
      Medical/Nursing Services
    • Addus HomeCare Announces Retirement of Laurie Manning

      Robby Stevenson Named Company's Chief Human Resource Officer Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that Laurie Manning retired from her position as Executive Vice President and Chief Human Resource Officer, effective June 11, 2021. Robby Stevenson, Senior Vice President of Human Resources, has been promoted to Executive Vice President and Chief Human Resource Officer and will assume leadership in that area. Commenting on the announcement, Dirk Allison, Chairman and Chief Executive Officer, said, "Laurie has played an important role in the growth and success of Addus since she joined the Company in 2017. Our employees are our most impor

      6/14/21 8:00:00 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Names Veronica Hill-Milbourne And Esteban López, M.D. To Board Of Directors

      FRISCO, Texas, Jan. 11, 2021 /PRNewswire/ -- Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced that Veronica Hill-Milbourne and Esteban López, M.D. have been appointed to the Company's Board of Directors, effective January 11, 2021. Ms. Hill-Milbourne is President and Chief Executive Officer of Spectrum Health Services, Inc., with executive oversight of three Federally Qualified Health Centers located in Philadelphia, Pennsylvania. She previously served as Chief Executive Officer/State Director for Pathways by Atar Capital, with executive oversight of mental and behavioral health home and community-based service programs operating in 30 counties

      1/11/21 8:00:00 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13G/A filed by Addus HomeCare Corporation

      SCHEDULE 13G/A - Addus HomeCare Corp (0001468328) (Subject)

      5/13/25 3:50:10 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by Addus HomeCare Corporation

      10-Q - Addus HomeCare Corp (0001468328) (Filer)

      5/6/25 4:30:26 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • SEC Form 8-K filed by Addus HomeCare Corporation

      8-K - Addus HomeCare Corp (0001468328) (Filer)

      5/5/25 4:54:55 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    Financials

    Live finance-specific insights

    See more
    • Addus HomeCare Announces First Quarter 2025 Financial Results

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights: Net Service Revenues Grow 20.3% to $337.7 Million Net Income of $21.2 Million, or $1.16 per Diluted Share Adjusted Net Income per Diluted Share Increases 17.4% year-over-year to $1.42 Adjusted EBITDA Increases 25.1% year-over-year to $40.6 Million Cash Flow from Operations of $18.9 Million Overview Net service revenues were $337.7 million for the first quarter of 2025, a 20.3% increase compared with $280.7 million for the first quarter of 2024. Net income was $21.2 million for the first quar

      5/5/25 4:05:00 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Announces First Quarter 2025 Earnings Release and Conference Call

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that it will release earnings for the first quarter ended March 31, 2025, on Monday, May 5, 2025, after the market close. Addus HomeCare will host a conference call on Tuesday, May 6, 2025, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Brad Bickham, President and COO. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available through midnight on May 13,

      4/21/25 11:00:00 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Announces Fourth Quarter and Year End 2024 Financial Results

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the fourth quarter and year ended December 31, 2024. Fourth Quarter 2024 Highlights: Net Service Revenues Grow 7.5% to $297.1 Million Net Income of $19.5 Million, or $1.07 per Diluted Share Adjusted Net Income per Diluted Share Increases 4.6% year-over-year to $1.38 Adjusted EBITDA Increases 10.3% year-over-year to $37.8 Million Cash Flow from Operations of $10.4 Million Completed acquisition of Gentiva personal care operations Overview Net service revenues were $297.1 million for the fourth quarter of 2024, a 7.5% increase compared with $276.4 milli

      2/24/25 4:05:00 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care